Average Weight Loss On Mounjaro

Posted on September 15, 2026 by Sally-Anne Turner

If you’re considering Mounjaro (tirzepatide) for weight loss, one of your first questions is probably: how much weight can I realistically expect to lose? It’s a natural question, and one that deserves a thorough, honest answer. You’ve likely seen dramatic before-and-after photos online or heard impressive statistics quoted in news articles, but what do these numbers actually mean for you as an individual? Understanding average weight loss on Mounjaro can help you set realistic expectations and plan your weight management journey with confidence.

At Bodyline Clinic, we’ve supported thousands of patients through their weight loss journeys, and we understand that everyone’s experience with treatment is different. Clinical trials have shown that tirzepatide can produce substantial weight loss in adults who meet the criteria for treatment. However, average results do not predict exactly how much an individual will lose. Your response will depend on factors including your starting weight, treatment dose, adherence, health, lifestyle and individual biology.

Understanding Clinical Trial Results: The Foundation of Evidence

When discussing average weight loss on Mounjaro, we need to start with the clinical trial data that forms the foundation of our understanding. The SURMOUNT trials provide some of the most important evidence on tirzepatide for weight management in adults with overweight or obesity.

The SURMOUNT-1 Trial: Landmark Weight Loss Data

The SURMOUNT-1 trial studied 2,539 adults with obesity or overweight and at least one weight-related health condition, excluding people with diabetes. Participants received once-weekly tirzepatide at doses of 5mg, 10mg or 15mg, or placebo, alongside lifestyle intervention including dietary and physical activity advice.

After 72 weeks of treatment, participants receiving tirzepatide lost an average of 15.0% of their body weight with the 5mg dose, 19.5% with the 10mg dose and 20.9% with the 15mg dose. Participants receiving placebo lost an average of 3.1%.

The results also showed that a substantial proportion of participants achieved clinically meaningful levels of weight loss. At the 15mg dose, 90.9% of participants achieved at least 5% weight loss, 83.5% achieved at least 10%, 70.6% achieved at least 15%, 56.7% achieved at least 20%, and 40.9% achieved at least 25%.

These results demonstrate the potential for substantial weight loss with tirzepatide, but they should be viewed as averages from a controlled clinical trial rather than a guarantee of what any individual patient will achieve.

Real-World Results: What We See at Bodyline Clinic

Clinical trials provide controlled environments with strict protocols, while real-world treatment involves people with different medical histories, lifestyles, starting weights and treatment goals.

Individual results can therefore vary considerably. Some people experience relatively rapid weight loss early in treatment, while others respond more gradually. Weight loss can also fluctuate from week to week rather than following a perfectly predictable pattern.

The aim of treatment is not to match another person’s result, but to establish a safe and effective treatment plan that is appropriate for you.

Weight Loss Patterns: What to Expect

Understanding the general timeline of weight loss on Mounjaro can help you maintain realistic expectations. Weight loss with tirzepatide isn’t necessarily instantaneous or linear.

The First Four Weeks: Initial Adjustment Period

During your first month on Mounjaro, you’ll typically start on the lowest dose, 2.5mg once weekly. This is the initiation dose and is used for the first four weeks before increasing to 5mg, provided treatment is appropriate and well tolerated.

There is no clinically established amount of weight that everyone should expect to lose during these first four weeks. Some people lose weight relatively quickly, while others experience little measurable change initially.

Early changes in body weight can also reflect changes in food intake, fluid balance and bowel habits, rather than representing a predictable amount of fat loss.

You may notice changes beyond the number on the scales during this period. Some people experience reduced appetite or feel satisfied with smaller portions. Others notice little change initially. Both responses can occur, and an individual’s early response does not necessarily predict their longer-term outcome.

Months Two and Three: Continuing Treatment

As you progress through the prescribed dose-escalation schedule, your dose may increase from 2.5mg to 5mg after four weeks and potentially to higher doses thereafter, depending on your individual response and tolerability.

Weight loss can continue during this period, but there is no single amount that everyone should expect to lose.

Some people may experience more noticeable weight loss as their treatment progresses, while others may have a more gradual response. The clinical trials demonstrate that weight loss can continue over many months, rather than being confined to a particular two- or three-month period.

Gastrointestinal side effects such as nausea, diarrhoea and constipation can occur, particularly during dose escalation. These effects often become less troublesome over time, although this varies between individuals.

Staying adequately hydrated and following dietary advice from your healthcare professional can help you manage some treatment-related gastrointestinal symptoms.

Months Four to Six: Continued Progress

By months four to six, some patients will have progressed through several dose increases, while others may remain on a lower dose because of individual response or tolerability.

Weight loss can continue during this period. However, the rate at which someone loses weight is highly individual, and it is not appropriate to assume that everyone will follow the same trajectory.

This can also be a useful period for establishing sustainable eating and physical activity habits alongside medical treatment.

Mounjaro should be viewed as one part of a broader weight-management approach, rather than as a replacement for healthy lifestyle measures.

Months Seven to Twelve: Longer-Term Treatment

As treatment continues, weight loss may continue, although the rate can vary considerably between individuals.

Longer-term clinical trial data show that substantial weight reduction can be maintained or increased with continued tirzepatide treatment. However, individual results will depend on factors including dose, treatment response, adherence and health circumstances.

The decision about how long to continue Mounjaro should be made in consultation with your healthcare provider, taking into account your overall health, treatment response, weight-management goals and the benefits and risks of continuing treatment.

Factors That Influence Your Individual Results

Whilst clinical trials provide valuable average data, your personal weight loss on Mounjaro will be influenced by numerous individual factors. Understanding these variables helps you avoid unfair comparisons with others on the same treatment.

Starting Weight and BMI

Your starting weight can influence the absolute amount of weight you lose. Someone with a higher starting weight may lose more kilograms than someone with a lower starting weight while achieving a similar percentage reduction in body weight.

For example, a 20% reduction in body weight would represent 24kg for someone weighing 120kg, compared with 16kg for someone weighing 80kg.

This is one reason healthcare professionals often consider weight loss as a percentage of starting body weight rather than looking only at the number of kilograms lost.

Age and Metabolic Health

Individual health characteristics can influence how you respond to weight-management treatment. Factors such as age, existing medical conditions, medications and metabolic health may all be relevant when your healthcare professional assesses your treatment.

Age alone does not determine how much weight you will lose on Mounjaro.

Lifestyle Factors: Diet and Exercise

Mounjaro is prescribed alongside a reduced-calorie diet and increased physical activity for weight management.

Healthy eating patterns and regular physical activity can support overall health during treatment. However, this does not mean you need to follow an excessively restrictive diet or undertake intensive exercise.

The most appropriate approach will depend on your health, fitness, preferences and individual circumstances.

Regular movement, including walking and resistance exercise, can support physical fitness and help maintain muscle strength during weight loss.

Previous Weight Loss Attempts and Metabolic Adaptation

If you’ve previously lost and regained weight, your body may have undergone physiological adaptations associated with weight loss and energy restriction. These adaptations can make maintaining weight loss challenging.

However, it isn’t possible to predict an individual’s response to tirzepatide simply from their previous dieting history.

Your healthcare professional can consider your previous weight-management experiences alongside your current health and treatment goals.

Medication Adherence and Consistency

Using Mounjaro according to your prescribed schedule is important for safe and effective treatment.

Mounjaro is administered once weekly. If you miss a dose, follow the instructions provided with your medicine or speak to your healthcare professional rather than changing your treatment schedule yourself.

Taking your injections on the same day each week can help you maintain a consistent routine.

Supporting Your Weight Loss Results on Mounjaro

Whilst Mounjaro can be an effective medical treatment for weight management, there are steps you can take alongside treatment to support your overall health and help preserve muscle during weight loss.

Protein Prioritisation Strategy

Eating adequate protein during weight loss can help support muscle maintenance, particularly when combined with resistance exercise.

Rather than following a single protein target that applies to everyone, your nutritional requirements should be considered individually.

Aim to include a source of protein in your meals where appropriate. Options include lean meat, fish, eggs, dairy products, legumes and plant-based alternatives.

A dietitian or healthcare professional can provide personalised nutritional advice if you are unsure how much protein you need.

Hydration and Its Impact on Treatment

Adequate hydration is important when taking Mounjaro, particularly because gastrointestinal side effects such as vomiting or diarrhoea can increase the risk of dehydration.

There is not a single amount of water that is appropriate for every person. Your fluid requirements depend on factors such as your body size, activity level, environment and health.

Rather than aiming for a universal target such as two litres every day, focus on maintaining adequate hydration and follow any personalised advice provided by your healthcare professional.

Movement and Exercise: Finding What Works for You

You don’t need to become a gym enthusiast to benefit from physical activity during Mounjaro treatment.

For many people, increasing daily walking is a practical starting point. Resistance training can also be particularly useful during weight loss because it helps support muscle strength and function.

The most appropriate type and amount of exercise will depend on your fitness level, health and individual circumstances.

Sleep and Stress Management

Good sleep and effective stress management are important components of overall health and can support healthy weight-management behaviours.

However, it would be too simplistic to suggest that poor sleep or stress directly determines how quickly someone loses weight on Mounjaro.

Prioritising sufficient sleep, maintaining regular routines and finding stress-management strategies that work for you can support your general wellbeing throughout treatment.

When Results Plateau: Understanding and Managing Stalls

Periods where weight loss slows or temporarily stops can occur during weight management. A plateau does not automatically mean that Mounjaro has stopped working.

Why Plateaus Happen

As body weight decreases, the body generally requires fewer calories to maintain its new weight. Changes in energy expenditure and fluid balance can also affect what you see on the scales.

Day-to-day fluctuations can sometimes make it difficult to distinguish a genuine plateau from normal changes in body weight.

Other factors, including changes in food intake, physical activity, illness, medication and hormonal fluctuations, can also influence weight.

What to Do If Your Weight Loss Slows

If your weight has remained stable for a prolonged period, discuss this with your healthcare professional rather than changing your Mounjaro dose yourself.

Your healthcare team may review your treatment, eating patterns, physical activity, adherence, side effects and other health factors.

Increasing the Mounjaro dose may be appropriate for some people, but only when it is clinically appropriate and prescribed according to the recommended dosing schedule.

Taking body measurements alongside your weight can also provide additional information about changes in your body composition and progress.

Comparing Mounjaro to Other Weight Loss Treatments

Understanding how Mounjaro’s average weight loss compares to other treatments can help contextualise its effectiveness and may inform your treatment decisions.

Mounjaro Versus Wegovy

Clinical trials have shown that both Mounjaro (tirzepatide) and Wegovy (semaglutide) can produce substantial weight loss when used alongside lifestyle interventions.

In the SURMOUNT-1 trial, participants receiving tirzepatide achieved average weight reductions of 15.0% with 5mg, 19.5% with 10mg and 20.9% with 15mg after 72 weeks.

More importantly, SURMOUNT-5 directly compared tirzepatide with semaglutide in adults with obesity who did not have type 2 diabetes. After 72 weeks, the average reduction in body weight was 20.2% with tirzepatide compared with 13.7% with semaglutide.

Tirzepatide therefore produced a greater average reduction in body weight than semaglutide in this particular head-to-head trial.

However, these figures represent average results from clinical trials and do not predict exactly how much weight an individual will lose. The two treatments were also used at their respective maximum tolerated doses, so the results should not be interpreted as a direct comparison of every available dose.

Mounjaro Versus Traditional Weight Loss Methods

Mounjaro is a medical treatment that can be used alongside dietary and physical activity measures for eligible patients.

It should not be viewed as a replacement for healthy lifestyle habits. Instead, it forms part of a broader approach to weight management that can include nutritional support, physical activity and ongoing clinical monitoring.

Long-Term Weight Maintenance After Mounjaro

Achieving weight loss is one challenge, but maintaining that loss long-term is another. Understanding what may happen when treatment is stopped can help you have realistic conversations with your healthcare provider.

Continuing Treatment for Maintenance

Mounjaro is indicated for both weight loss and weight maintenance in eligible adults.

Some people may continue treatment after achieving an initial weight-loss goal if their healthcare professional considers ongoing treatment appropriate.

The evidence from SURMOUNT-4 demonstrates why long-term treatment may be important for some patients. Participants first received tirzepatide for 36 weeks and achieved substantial weight loss. Those who then switched to placebo regained an average of 14.0% of their body weight during the following 52 weeks, while those who continued tirzepatide lost an additional 5.5% on average.

These results demonstrate that stopping tirzepatide can lead to significant weight regain in many people, whereas continued treatment helped maintain and extend weight loss in the trial.

The decision about whether to continue treatment long-term should be made collaboratively with your healthcare provider, taking into account your health, treatment response, risk of weight regain and personal circumstances.

Stopping Mounjaro

If you are considering stopping Mounjaro, speak to your healthcare professional first.

There is not a universal requirement to gradually taper the dose over several months before stopping Mounjaro. Your healthcare professional can advise you on the most appropriate approach based on your individual circumstances and discuss strategies for managing the risk of weight regain.

If treatment is stopped, continuing healthy eating patterns and physical activity can remain important components of long-term weight management.

Setting Realistic Expectations for Your Journey

Whilst understanding average weight loss on Mounjaro is helpful, it’s crucial to set realistic, personalised expectations for your own journey. Your results will be unique to you and influenced by your individual biology, treatment dose, health, lifestyle and circumstances.

There is no single amount of weight that you should expect to lose each week or month.

The clinical trial results demonstrate what can be achieved on average over longer treatment periods, but they should not be treated as a promise of what you personally will achieve.

Beyond the Numbers: Non-Scale Victories

Weight loss is about more than just the number on the scales. Many patients find that meaningful changes aren’t captured by that number alone.

Improved mobility, changes in blood pressure or blood glucose, improved fitness and greater confidence may all be important outcomes alongside weight loss.

For people living with obesity-related health conditions, weight reduction may also form part of a broader approach to improving health.

The Importance of Patient Support

Ongoing clinical support can be an important part of weight-management treatment.

Regular reviews with healthcare professionals provide an opportunity to assess your response to Mounjaro, monitor side effects, discuss nutrition and physical activity, and determine whether your treatment plan remains appropriate.

This support can be particularly important if you have other medical conditions, take multiple medicines, experience significant side effects or find that your weight loss has slowed.

Taking the Next Step: Starting Your Mounjaro Journey

If you’re considering Mounjaro for weight loss, understanding average results is just the beginning. The next step is determining whether this treatment is appropriate for you and developing a personalised plan.

At Bodyline Clinic, we take a comprehensive approach to weight management, ensuring that Mounjaro is appropriate for your individual circumstances and supporting you throughout your treatment journey.

Our experienced medical team will assess your health history, discuss your goals, and create a treatment plan tailored to your needs.

We understand that starting any weight-loss treatment can feel daunting. You might have questions about side effects, costs, how much weight you may lose, or whether you’ll be able to maintain your results. These concerns are completely valid, and we’re here to address them and help you make an informed decision about your health.

Mounjaro has demonstrated substantial weight-loss potential in clinical trials. However, the most important result is finding a treatment approach that is safe, appropriate and sustainable for you.

Whether you’re struggling with obesity-related health conditions, have tried multiple weight-loss approaches without lasting success, or want to explore medically supported weight management, Mounjaro may be an option worth discussing with a qualified healthcare professional.

The journey to a healthier weight starts with understanding your options, and we’re here to support you every step of the way.

Book a consultation today to discover how we can help you achieve your weight-loss goals. Our expert team at Bodyline Clinic will assess your individual needs, answer your questions, and help you determine whether Mounjaro is the right choice for your weight-management journey.